Skip to main navigation Skip to search Skip to main content

Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes

  • Steven W. de Taeye
  • , Gabriel Ozorowski
  • , Alba Torrents de la Peña
  • , Miklos Guttman
  • , Jean-Philippe Julien
  • , Tom L. G. M. van den Kerkhof
  • , Judith A. Burger
  • , Laura K. Pritchard
  • , Pavel Pugach
  • , Anila Yasmeen
  • , Jordan Crampton
  • , Joyce Hu
  • , Ilja Bontjer
  • , Jonathan L. Torres
  • , Heather Arendt
  • , Joanne DeStefano
  • , Wayne C. Koff
  • , Hanneke Schuitemaker
  • , Dirk Eggink
  • , Ben Berkhout
  • Hansi Dean, Celia Labranche, Shane Crotty, Max Crispin, David C. Montefiori, P. J. Klasse, Kelly K. Lee, John P. Moore, Ian A. Wilson, Andrew B. Ward, Rogier W. Sanders

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The envelope glycoprotein trimer mediates HIV-1 entry into cells. The trimer is flexible, fluctuating between closed and more open conformations and sometimes sampling the fully open, CD4-bound form. We hypothesized that conformational flexibility and transient exposure of non-neutralizing, immunodominant epitopes could hinder the induction of broadly neutralizing antibodies (bNAbs). We therefore modified soluble Env trimers to stabilize their closed, ground states. The trimer variants were indeed stabilized in the closed conformation, with a reduced ability to undergo receptor-induced conformational changes and a decreased exposure of non-neutralizing V3-directed antibody epitopes. In rabbits, the stabilized trimers induced similar autologous Tier-1B or Tier-2 NAb titers to those elicited by the corresponding wild-type trimers but lower levels of V3-directed Tier-1A NAbs. Stabilized, closed trimers might therefore be useful components of vaccines aimed at inducing bNAbs
Original languageEnglish
Pages (from-to)1702-1715
JournalCell
Volume163
Issue number7
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes'. Together they form a unique fingerprint.

Cite this